ArticleDiabetes care2022

Three Sides to the Story: Adherence Trajectories During the First Year of SGLT2 Inhibitor Therapy Among Medicare Beneficiaries.

Chelsea E Hawley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.